- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Innovus Pharmaceuticals Outperforms Antibe Therapeutics in Revenue and Earnings
Innovus Pharmaceuticals shows stronger financial metrics and institutional ownership compared to Antibe Therapeutics.
Mar. 23, 2026 at 9:18am
Got story updates? Submit your updates here. ›
This article compares the financial performance and valuation of Innovus Pharmaceuticals and Antibe Therapeutics, two pharmaceutical companies. Innovus Pharmaceuticals has higher revenue, earnings per share, and stronger institutional ownership compared to Antibe Therapeutics. The article provides a detailed breakdown of the key financial metrics and business operations for both companies.
Why it matters
This comparison highlights the relative strengths and weaknesses of the two pharmaceutical companies, which can be useful information for investors and industry analysts evaluating the competitive landscape and growth prospects in this sector.
The details
The key findings from the comparison show that Innovus Pharmaceuticals has higher revenue, earnings per share, and stronger institutional ownership compared to Antibe Therapeutics. Innovus Pharmaceuticals also outperforms Antibe Therapeutics on 7 out of 10 factors analyzed, including net margins, return on equity, and return on assets.
- The data in this article is current as of March 23, 2026.
The players
Innovus Pharmaceuticals, Inc.
A pharmaceutical company that engages in the development, licensing, and commercialization of non-prescription medicines and consumer care products in the United States.
Antibe Therapeutics Inc.
A pharmaceutical development company that originates, develops, and out-licenses patent novel therapeutics and medical devices in the areas of pain, inflammation and regenerative medicine.
The takeaway
This analysis highlights the relative financial and operational strengths of Innovus Pharmaceuticals compared to Antibe Therapeutics, providing investors and industry observers with useful insights to evaluate the competitive dynamics in the pharmaceutical sector.
